These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8556486)

  • 21. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
    Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
    J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection.
    Wagner DK; Graham BS; Wright PF; Walsh EE; Kim HW; Reimer CB; Nelson DL; Chanock RM; Murphy BR
    J Clin Microbiol; 1986 Aug; 24(2):304-6. PubMed ID: 3755731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic and local immune responses of four cases with lower respiratory tract illness due to reinfection with respiratory syncytial virus.
    Tsutsumi H; Sone S; Takeuchi R; Osaki M; Chiba S
    J Infect; 1997 Sep; 35(2):189-92. PubMed ID: 9354358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.
    Johnson PR; Olmsted RA; Prince GA; Murphy BR; Alling DW; Walsh EE; Collins PL
    J Virol; 1987 Oct; 61(10):3163-6. PubMed ID: 3305988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults.
    Wagner DK; Nelson DL; Walsh EE; Reimer CB; Henderson FW; Murphy BR
    J Clin Microbiol; 1987 Apr; 25(4):748-50. PubMed ID: 3571485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.
    Murphy BR; Walsh EE
    J Clin Microbiol; 1988 Aug; 26(8):1595-7. PubMed ID: 2459154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children.
    Kasel JA; Walsh EE; Frank AL; Baxter BD; Taber LH; Glezen WP
    Viral Immunol; 1987-1988; 1(3):199-205. PubMed ID: 3509676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections.
    Wagner DK; Muelenaer P; Henderson FW; Snyder MH; Reimer CB; Walsh EE; Anderson LJ; Nelson DL; Murphy BR
    J Clin Microbiol; 1989 Mar; 27(3):589-92. PubMed ID: 2715331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
    Front Immunol; 2019; 10():706. PubMed ID: 30984206
    [No Abstract]   [Full Text] [Related]  

  • 30. Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater
    Zhao M; Zheng ZZ; Chen M; Modjarrad K; Zhang W; Zhan LT; Cao JL; Sun YP; McLellan JS; Graham BS; Xia NS
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection.
    Brandenburg AH; Groen J; van Steensel-Moll HA; Claas EC; Rothbarth PH; Neijens HJ; Osterhaus AD
    J Med Virol; 1997 May; 52(1):97-104. PubMed ID: 9131465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.
    Murphy BR; Sotnikov A; Paradiso PR; Hildreth SW; Jenson AB; Baggs RB; Lawrence L; Zubak JJ; Chanock RM; Beeler JA
    Vaccine; 1989 Dec; 7(6):533-40. PubMed ID: 2692334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.
    Anderson LJ; Hierholzer JC; Tsou C; Hendry RM; Fernie BF; Stone Y; McIntosh K
    J Infect Dis; 1985 Apr; 151(4):626-33. PubMed ID: 2579169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serodiagnosis of respiratory syncytial virus (RSV) infection in children as measured by detection of RSV-specific immunoglobulins G, M, and A with enzyme-linked immunosorbent assay.
    Meddens MJ; Herbrink P; Lindeman J; van Dijk WC
    J Clin Microbiol; 1990 Jan; 28(1):152-5. PubMed ID: 2298874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.
    García-Barreno B; Palomo C; Peñas C; Delgado T; Perez-Breña P; Melero JA
    J Virol; 1989 Feb; 63(2):925-32. PubMed ID: 2463385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses.
    Welliver RC; Kaul TN; Putnam TI; Sun M; Riddlesberger K; Ogra PL
    J Pediatr; 1980 May; 96(5):808-13. PubMed ID: 7365579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
    van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR
    J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory syncytial virus-specific immunoglobulins in preterm infants.
    de Sierra TM; Kumar ML; Wasser TE; Murphy BR; Subbarao EK
    J Pediatr; 1993 May; 122(5 Pt 1):787-91. PubMed ID: 8496762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The local antibody response to R.S. virus infection in the respiratory tract.
    Scott R; Gardner PS
    J Hyg (Lond); 1974 Feb; 72(1):111-20. PubMed ID: 4206147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.